Related references
Note: Only part of the references are listed.Tumor flare after start of RAF inhibition in KRAS mutated NSCLC: A case report
Wouter W. Mellema et al.
LUNG CANCER (2015)
Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma
A. Grey et al.
INTERNAL MEDICINE JOURNAL (2014)
BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia
Niuscha Yaktapour et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
COX-2 inhibition prevents the appearance of cutaneous squamous cell carcinomas accelerated by BRAF inhibitors
Helena Escuin-Ordinas et al.
MOLECULAR ONCOLOGY (2014)
Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies
Omar Abdel-Wahab et al.
CANCER DISCOVERY (2014)
BRAF Inhibitor-Driven Tumor Proliferation in a KRAS-Mutated Colon Carcinoma Is Not Overcome by MEK1/2 Inhibition
Miles C. Andrews et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Paradoxical oncogenesis-the long-term effects of BRAF inhibition in melanoma
Geoffrey T. Gibney et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma
Mario E. Lacouture et al.
ONCOLOGIST (2013)
Induction of Cutaneous Squamous Cell Carcinomas by RAF Inhibitors: Cause for Concern?
Mario E. Lacouture et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective BRAF Inhibition
Lisa Zimmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
RAF around the Edges - The Paradox of BRAF Inhibitors
Ashani T. Weeraratna
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Progression of RAS-Mutant Leukemia during RAF Inhibitor Treatment
Margaret K. Callahan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikos I. Poulikakos et al.
NATURE (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Share Paper
